|
1
|
Srivatanakul P, Sriplung H and Deerasamee
S: Epidemiology of liver cancer: an overview. Asian Pac J Cancer
Prev. 5:118–125. 2004.
|
|
2
|
Lavanchy D: Hepatitis B virus
epidemiology, disease burden, treatment, and current and emerging
prevention and control measures. J Viral Hepat. 11:97–107. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Serag HB and Mason AC: Risk factors for
the rising rates of primary liver cancer in the United States. Arch
Intern Med. 160:3227–3230. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baan R, Straif K, Grosse Y, et al:
Carcinogenicity of alcoholic beverages. Lancet Oncol. 8:292–293.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Girard M, Jacquemin E, Munnich A, Lyonnet
S and Henrion-Caude A: miR-122, a paradigm for the role of
microRNAs in the liver. J Hepatol. 48:648–656. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
O’Connell RM, Rao DS, Chaudhuri AA and
Baltimore D: Physiological and pathological roles for microRNAs in
the immune system. Nat Rev Immunol. 10:111–122. 2010.PubMed/NCBI
|
|
7
|
Skaftnesmo KO, Prestegarden L, Micklem DR
and Lorens JB: microRNAs in tumorigenesis. Curr Pharm Biotechnol.
8:320–325. 2007. View Article : Google Scholar
|
|
8
|
Calin GA, Sevignani C, Dumitru CD, et al:
Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guttilla IK and White BA: Coordinate
regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast
cancer cells. J Biol Chem. 284:23204–23216. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu MC, Lee DF, Xia W, et al: IkappaB
kinase promotes tumorigenesis through inhibition of forkhead
FOXO3a. Cell. 117:225–237. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin H, Dai T, Xiong H, et al: Unregulated
miR-96 induces cell proliferation in human breast cancer by
downregulating transcriptional factor FOXO3a. PLoS One.
5:e157972010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pineau P, Volinia S, McJunkin K, et al:
miR-221 overexpression contributes to liver tumorigenesis. Proc
Natl Acad Sci USA. 107:264–269. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Greer EL and Brunet A: FOXO transcription
factors at the interface between longevity and tumor suppression.
Oncogene. 24:7410–7425. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Myatt SS, Wang J, Monteiro LJ, et al:
Definition of microRNAs that repress expression of the tumor
suppressor gene FOXO1 in endometrial cancer. Cancer Res.
70:367–377. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He XX, Chang Y, Meng FY, et al:
microRNA-375 targets AEG-1 in hepatocellular carcinoma and
suppresses liver cancer cell growth in vitro and in vivo. Oncogene.
31:3357–3369. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Samarin J, Rehm M, Krueger B, Waschke J
and Goppelt-Struebe M: Up-regulation of connective tissue growth
factor in endothelial cells by the microtubule-destabilizing agent
combretastatin A-4. Mol Cancer Res. 7:180–188. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zrelli H, Matsuoka M, Kitazaki S, Zarrouk
M and Miyazaki H: Hydroxytyrosol reduces intracellular reactive
oxygen species levels in vascular endothelial cells by upregulating
catalase expression through the AMPK-FOXO3a pathway. Eur J
Pharmacol. 660:275–282. 2011. View Article : Google Scholar
|
|
18
|
Gregory RI and Shiekhattar R: microRNA
biogenesis and cancer. Cancer Res. 65:3509–3512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Calin GA and Croce CM: microRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar
|
|
21
|
Murakami Y, Yasuda T, Saigo K, et al:
Comprehensive analysis of microRNA expression patterns in
hepatocellular carcinoma and non-tumorous tissues. Oncogene.
25:2537–2545. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jiang J, Gusev Y, Aderca I, et al:
Association of microRNA expression in hepatocellular carcinomas
with hepatitis infection, cirrhosis, and patient survival. Clin
Cancer Res. 14:419–427. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang YS, Dai Y, Yu XF, et al: Microarray
analysis of microRNA expression in hepatocellular carcinoma and
non-tumorous tissues without viral hepatitis. J Gastroenterol
Hepatol. 23:87–94. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ladeiro Y, Couchy G, Balabaud C, et al:
microRNA profiling in hepatocellular tumors is associated with
clinical features and oncogene/tumor suppressor gene mutations.
Hepatology. 47:1955–1963. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bandres E, Cubedo E, Agirre X, et al:
Identification by Real-time PCR of 13 mature microRNAs
differentially expressed in colorectal cancer and non-tumoral
tissues. Mol Cancer. 5:292006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Agirre X, Jimenez-Velasco A, San
Jose-Eneriz E, et al: Down-regulation of hsa-miR-10a in chronic
myeloid leukemia CD34+ cells increases USF2-mediated
cell growth. Mol Cancer Res. 6:1830–1840. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Han Y, Chen J, Zhao X, et al: microRNA
expression signatures of bladder cancer revealed by deep
sequencing. PLoS One. 6:e182862011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Derynck R, Akhurst RJ and Balmain A:
TGF-beta signaling in tumor suppression and cancer progression. Nat
Genet. 29:117–129. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang H and Tindall DJ: Dynamic FoxO
transcription factors. J Cell Sci. 120:2479–2487. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang JY, Xia W and Hu MC: Ionizing
radiation activates expression of FOXO3a, Fas ligand, and Bim, and
induces cell apoptosis. Int J Oncol. 29:643–648. 2006.PubMed/NCBI
|
|
32
|
Aoki M, Jiang H and Vogt PK: Proteasomal
degradation of the FoxO1 transcriptional regulator in cells
transformed by the P3k and Akt oncoproteins. Proc Natl Acad Sci
USA. 101:13613–13617. 2004. View Article : Google Scholar : PubMed/NCBI
|
